UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

Nature communications, 2019-02, Vol.10 (1), p.863-863, Article 863

2019

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

The New England journal of medicine, 2009-12, Vol.361 (23), p.2209-2220

2009

Link zum Volltext

Verfügbarkeit prüfen

P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

Retrovirology, 2009-10, Vol.6 (S3), p.P193-P193, Article P193

2009

Link zum Volltext

Verfügbarkeit prüfen

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

AIDS research and human retroviruses, 2012-11, Vol.28 (11), p.1444

2012

Link zum Volltext

Verfügbarkeit prüfen

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

Retrovirology, 2009-10, Vol.6 (S3), p.O30-O30, Article O30

2009

Link zum Volltext

Verfügbarkeit prüfen

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.5166-5176

2012

Link zum Volltext

Verfügbarkeit prüfen

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site

Retrovirology, 2012-09, Vol.9 (S2), p.P107-P107, Article P107

2012

Link zum Volltext

Verfügbarkeit prüfen

Vector induced skewing of antibody Fc-effector functions

Retrovirology, 2012-09, Vol.9 (S2), p.P361-P361, Article P361

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

Retrovirology, 2012-09, Vol.9 (S2), p.P78-P78, Article P78

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 subtypes and male-to-female transmission in Thailand

The Lancet (British edition), 1995-04, Vol.345 (8957), p.1078-1083

1995

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

Retrovirology, 2012-09, Vol.9 (S2), p.O39-O39, Article O39

2012

Link zum Volltext

Verfügbarkeit prüfen

Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants

Clinical and Vaccine Immunology, 2014-03, Vol.21 (3), p.391-398

2014

Link zum Volltext

Verfügbarkeit prüfen

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

Retrovirology, 2012-09, Vol.9 (S2), p.O31-O31, Article O31

2012

Link zum Volltext

Verfügbarkeit prüfen

T-cell based sieve analysis ties HLA A02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

Retrovirology, 2012-09, Vol.9 (S2), p.O61-O61, Article O61

2012

Link zum Volltext

Verfügbarkeit prüfen

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

Tissue antigens, 2015-02, Vol.85 (2), p.117-126

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148)

Vaccine, 2011-06, Vol.29 (25), p.4285-4292

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV/AIDS preventive vaccine 'prime-boost' phase III trial : foundations and initial lessons learned from Thailand

AIDS (London), 2006-07, Vol.20 (11), p.1471-1479

2006

Link zum Volltext

Verfügbarkeit prüfen

Expanding research capacity and accelerating AIDS vaccine development in Asia

Southeast Asian journal of tropical medicine and public health, 2008-07, Vol.39 (4), p.766-784

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand

Vaccine, 2004-02, Vol.22 (8), p.975-983

2004

Link zum Volltext

Verfügbarkeit prüfen

ACCELERATING THE DEVELOPMENT OF AN AIDS VACCINE: THE AIDS VACCINE FOR ASIA NETWORK (AVAN)

Southeast Asian journal of tropical medicine and public health, 2011-09, Vol.42 (5), p.1130-1146

2011

Link zum Volltext

Verfügbarkeit prüfen

A reply to the Letter to the Editor by Mäkelä, Herva and Nohynek in response to the article by Rerks-Ngarm S, Treleaven SC, Chunsuttiwat S, Muangchana C, Jolley D, Brooks A, Dejsirilert S, Warintrawat S, Guiver M, Kunasol P, Maynard JE, Biggs B-A, Steinhoff M. Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. Vaccine 2004;22:975–83

Vaccine, 2005-11, Vol.23 (46), p.5284-5285

2005

Link zum Volltext

Verfügbarkeit prüfen

Sex-ratio patterns of AIDS patients in Thailand

Journal of the Medical Association of Thailand, 1997, Vol.80 (1), p.34-46

RERKS-NGARM, S

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(126)

Sprache

Englisch
(126)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Humans
(84)
Life Sciences & Biomedicine
(75)
Aids Vaccines - Immunology
(55)
Hiv
(48)
Vaccines
(48)
Hiv-1 - Immunology
(47)
Human Immunodeficiency Virus
(46)
Hiv Infections - Prevention & Control
(41)
Aids
(40)
Immunology
(38)
Infectious Diseases
(38)
Acquired Immune Deficiency Syndrome
(37)
Hiv Infections - Immunology
(37)
Virology
(37)
Hiv Antibodies - Immunology
(34)
Infections
(29)
Hiv Envelope Protein Gp120 - Immunology
(27)
Aids Vaccines - Administration & Dosage
(23)
Female
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(17)
Journal Of Virology
(15)
Retrovirology
(10)
Plos Pathogens
(9)
Vaccine
(7)
Aids Research And Human Retroviruses
(5)
The Journal Of Infectious Diseases
(5)
Ebiomedicine
(4)
Jci Insight
(4)
Plos Computational Biology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site

Vector induced skewing of antibody Fc-effector functions

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

HIV-1 subtypes and male-to-female transmission in Thailand

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

T-cell based sieve analysis ties HLA A02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148)

HIV/AIDS preventive vaccine 'prime-boost' phase III trial : foundations and initial lessons learned from Thailand

Expanding research capacity and accelerating AIDS vaccine development in Asia

Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand

ACCELERATING THE DEVELOPMENT OF AN AIDS VACCINE: THE AIDS VACCINE FOR ASIA NETWORK (AVAN)

Sex-ratio patterns of AIDS patients in Thailand

Suchergebnisse filtern